{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T18:40:02Z","timestamp":1792780802861,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02618-9","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:24:58Z","timestamp":1792733098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lessons from dog lifespan therapeutics for their human companions"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5506-4499","authenticated-orcid":false,"given":"Matthew","family":"Peloquin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine-Lea","family":"Halioua-Haubold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"1","key":"2618_CR1","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41467-025-67701-9","volume":"17","author":"F Kong","year":"2026","unstructured":"Kong F, et al. Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases. Nat Commun. 2026;17:972. https:\/\/doi.org\/10.1038\/s41467-025-67701-9.","journal-title":"Nat Commun"},{"key":"2618_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pcad.2023.10.003","volume":"81","author":"JH O'Keefe","year":"2023","unstructured":"O\u2019Keefe JH, Weidling R, O\u2019Keefe EL, Franco WG. SGLT inhibitors for improving Healthspan and lifespan. Prog Cardiovasc Dis. 2023;81:2\u20139.","journal-title":"Prog Cardiovasc Dis."},{"key":"2618_CR3","doi-asserted-by":"publisher","unstructured":"Are GLP-1s the first longevity drugs? Nat Biotechnol. 2025;43:1741\u201342. https:\/\/doi.org\/10.1038\/s41587-025-02932-1.","DOI":"10.1038\/s41587-025-02932-1"},{"issue":"4","key":"2618_CR4","doi-asserted-by":"publisher","first-page":"e13596","DOI":"10.1111\/acel.13596","volume":"21","author":"AS Kulkarni","year":"2022","unstructured":"Kulkarni AS, Aleksic S, Berger DM, Sierra F, Kuchel GA, Barzilai N. Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization. Aging Cell. 2022;21(4):e13596. https:\/\/doi.org\/10.1111\/acel.13596.","journal-title":"Aging Cell."},{"issue":"20","key":"2618_CR5","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.3390\/ijms232012325","volume":"23","author":"R La Grotta","year":"2022","unstructured":"La Grotta R, Frig\u00e9 C, Matacchione G, Olivieri F, de Candia P, Ceriello A, Prattichizzo F. Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms. Int J Mol Sci. 2022;23(20):12325. https:\/\/doi.org\/10.3390\/ijms232012325.","journal-title":"Int J Mol Sci."},{"issue":"8131","key":"2618_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-026-10940-7","volume":"657","author":"Y Feng","year":"2026","unstructured":"Feng Y, Barthez M, Wang Y, Chen Y, Qiu H, Wang CL, Heydari K, Delcroix M, Rasmussen LJ, Bohr VA, Chen D. Late-life semaglutide treatment slows ageing and extends lifespan in female mice. Nature. 2026;657(8131):469\u201376. https:\/\/doi.org\/10.1038\/s41586-026-10940-7.","journal-title":"Nature."},{"issue":"4","key":"2618_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ppar\/prz018","volume":"29","author":"GA Fleming","year":"2019","unstructured":"Fleming GA, Zhao JH, Seoh TC, Barzilai N. A regulatory pathway for medicines that target aging. Public Policy Aging Rep. 2019;29(4):128\u201333. https:\/\/doi.org\/10.1093\/ppar\/prz018.","journal-title":"Public Policy Aging Rep."},{"key":"2618_CR8","unstructured":"US Food and Drug Administration. Applications covered by section 505(b)(2): draft guidance for industry. 1999. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/applications-covered-section-505b2."},{"key":"2618_CR9","unstructured":"Advanced Research Projects Agency for Health. PROSPR: Proactive Solutions for Prolonging Resilience. https:\/\/arpa-h.gov\/explore-funding\/programs\/prospr."},{"key":"2618_CR10","unstructured":"UT San Antonio. Barshop Institute to receive up to $38 million from ARPA-H, anchoring UT San Antonio as a national leader in aging and healthy longevity science. 2026. https:\/\/news.uthscsa.edu\/barshop-institute-to-receive-up-to-38-million-from-arpa-h-anchoring-ut-san-antonio-as-a-national-leader-in-aging-and-healthy-longevity-science\/."},{"key":"2618_CR11","unstructured":"Buck Institute for Research on Aging. THRIVE: Transforming health\u2014reclaiming intrinsic vitality for everyone. 2026. https:\/\/www.buckinstitute.org\/news\/thrive-transforming-health-reclaiming-intrinsic-vitality-for-everyone\/."},{"key":"2618_CR12","unstructured":"US Food and Drug Administration. FDA issues draft guidance on expanded conditional approval for certain animal drugs. 2019. https:\/\/www.fda.gov\/animal-veterinary\/cvm-updates\/fda-issues-draft-guidance-expanded-conditional-approval-certain-animal-drugs."},{"key":"2618_CR13","unstructured":"Loyal Animal Health. Loyal\u2019s latest milestone: the first longevity clinical study design supported by the FDA. 2023. https:\/\/loyal.com\/posts\/loyals-latest-milestone-the-first-longevity-clinical-study-design-supported-by-the-fda."},{"issue":"7\u20138","key":"2618_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00335-016-9638-7","volume":"27","author":"M Kaeberlein","year":"2016","unstructured":"Kaeberlein M, Creevy KE, Promislow DE. The dog aging project: translational geroscience in companion animals. Mamm Genome. 2016;27(7\u20138):279\u201388. https:\/\/doi.org\/10.1007\/s00335-016-9638-7.","journal-title":"Mamm Genome."}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02618-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02618-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02618-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T18:02:40Z","timestamp":1792778560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02618-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":14,"alternative-id":["2618"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02618-9","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Matthew Peloquin, Hubert C. Chen and Celine-Lea Halioua-Haubold are employees and\/or shareholders  of Loyal Animal Health Inc.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}